Keyphrases
Neuronal Ceroid Lipofuscinosis
83%
Batten Disease
71%
Tic Disorders
70%
Clinical Trials
52%
Tourette Syndrome
52%
CLN3 Disease
50%
Parkinson's Disease
46%
Rare Diseases
37%
Disease Score
35%
Gene-targeted Therapy
26%
Paediatric Neurology
25%
CLN3
23%
Sex Differences
23%
Diagnostic Interview Schedule
23%
Genetic Risk
23%
Early Treated
23%
Clinical Features
20%
Parent Report
20%
Neurological Diseases
19%
Pediatric Movement Disorders
18%
Attention Deficit Hyperactivity Disorder
18%
Movement Disorders
17%
Genotype
17%
Natural History
16%
Child Neurology
16%
Screening Tool
16%
Age of Onset
15%
Exploratory Trial
15%
Rare Disease Research
15%
Lysosomal Storage Disease
15%
Expert Clinician
15%
Longitudinal Observational Study
14%
Standardized Assessment
14%
Clinical Research
14%
Pediatric Population
13%
Screener
13%
Physical Impairment
12%
Neurodegenerative Diseases
12%
Leucine-rich Repeat Kinase 2 (LRRK2)
12%
Tidal Wave
11%
Flupirtine
11%
Juvenile Batten Disease
11%
Consensus Definition
11%
Disease Implications
11%
Children's Quality of Life
11%
Multicenter Clinical Trial
11%
Ultra-rare
11%
Equitable Development
11%
Area under the Curve
11%
Youth Self-Report
11%
Medicine and Dentistry
Disease
100%
Rare Disease
87%
Parkinson's Disease
69%
Batten Disease
63%
Clinical Trial
58%
Targeted Therapy
47%
Stereotypic Movement Disorder
39%
Pediatrics
36%
Neurologic Disease
28%
Epileptic Seizure
26%
Storage Disease
25%
Genetic Risk
23%
Pediatric Neurology
23%
Lysosomal Storage Disease
20%
Adverse Event
17%
Antisense Oligonucleotide
15%
Clinical Trial Design
15%
Disease Course
15%
Clinical Research
15%
Observational Study
14%
Genetic Disorder
14%
Placebo
14%
Apoplexy
13%
Prevalence
13%
Cohort Analysis
12%
Symptom
12%
Clinician
11%
Cell Line
11%
DNA Template
11%
Gilles De La Tourette Syndrome
11%
Genome Sequencing
11%
Randomized Clinical Trial
11%
Oligonucleotide Therapy
11%
Creatine
11%
Diagnostic Interview Schedule
11%
Molecular Diagnosis
11%
Retina Degeneration
11%
Phenotype
11%
Patient Registry
11%
Patient Advocate
11%
Tripeptidyl Peptidase I
11%
Enzyme Replacement Therapy
11%
Opiate
11%
Immunosuppressive Treatment
11%
Masturbation
11%
Infancy
11%
Cognition
11%
Arm
8%
Disease Exacerbation
7%
Neurodegeneration
7%
